Abstract
Background: Stereotactic radiosurgery (SRS) is indicated for a spectrum of brain tumors and is often an outpatient procedure, though severe disease may precipitate inpatient treatment. Readmission following inpatient SRS for brain tumors is not well understood. Objectives: To characterize rate, associative factors, and predictors of SRS readmission. Methods: Retrospective analysis of inpatients treated with SRS for brain neoplasms was conducted (2010-2014 Nationwide Readmissions Database). Diagnoses upon readmission were characterized. Associations with 30-day readmission were identified using multivariate analyses. Results: Of 2,553 patients undergoing SRS, 390 were readmitted (15.3%) within 30 days. Leading readmission diagnoses were infectious or embolic. Neurological readmissions of intracerebral hemorrhage (2.1%) and cerebral edema (1.5%) were rare. Malignant tumors (OR=1.60, p=0.007) and discharge to facility (OR=1.41, p=0.004) were associated with readmission. Conclusion: Inpatients receiving SRS for brain tumors have a 15.3% 30-day readmission rate. Neurologic readmissions were rare, underscoring the neurological safety of SRS, even in sick inpatients.
Original language | English (US) |
---|---|
Pages (from-to) | 101-119 |
Number of pages | 19 |
Journal | Journal of Radiosurgery and SBRT |
Volume | 6 |
Issue number | 2 |
State | Published - 2019 |
Keywords
- Cancer
- Complications
- Neurosurgery
- Oncology
- Quality improvement
ASJC Scopus subject areas
- Surgery
- Radiological and Ultrasound Technology
- Radiology Nuclear Medicine and imaging